Onyx Pharmaceuticals, Inc. Rejects Amgen's $10 Billion Offer, Looking for Suitor

Published: Jul 02, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Onyx Pharmaceuticals Inc. (ONXX), the maker of the cancer drug Nexavar, said it is in contact with other possible acquirers after rejecting an unsolicited $120-a-share cash takeover bid from Amgen Inc. (AMGN)

Help employers find you! Check out all the jobs and post your resume.

Back to news